Back

Corrigendum to: Association between use of novel glucose-lowering drugs and COVID-19 hospitalization and death in patients with type 2 diabetes: A nationwide registry analysis

European Heart Journal - Cardiovascular Pharmacotherapy

31 January 2023
Organised by: Logo
Read full article
ESC Journals
You may be interested in
thumbnail
Congress Presentation
Prospective Meta-Analysis of SGLT2 Inhibitor Randomized Trials in COVID-19
28 August 2023
thumbnail
Congress Session
Diabetes, obesity, and heart failure
19 May 2025
thumbnail
Congress Presentation
Lower risks of sodium glucose cotransporter 2 (SGLT2) inhibitors compared to dipeptidyl peptidase-4 (DPP4) inhibitors for new-onset hip fracture risks in patients with type-2 diabetes: A propensity sc
28 August 2023
thumbnail
Congress Presentation
Specific therapies of pulmonary hypertension and prognosis in COVID-19: 18-months analysis of BNP-PL national database.
27 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources